Newsroom | 28945 results

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that Guardant360® CDx has received CE-marking under Europe’s in Vitro Diagnostic Medical Devices Regulation as a companion diagnostic (CDx) to identify patients with estrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer who may benefit from treatment with ETCAMAH™ (camizestrant), AstraZeneca’s next-generation oral selective estrogen...

BOSTON--(BUSINESS WIRE)--Ginkgo Bioworks (NYSE: DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to support the National Science Foundation’s X-Labs program. Ginkgo’s support was announced today by Michael Kratsios, Director of the White House Office of Science and Technology Policy (OSTP), at the Science: A New Golden Age Summit in Washington, D.C. NSF X-Labs is a $1.5 billion, decade-long initiative to fund independent teams of researchers, engin...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the third quarter 2026 after market close on Thursday, November 5, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the company website at: www.guardanthealth.com. The webcast wil...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026...

BOSTON--(BUSINESS WIRE)--eClinical Solutions LLC, a global provider of digital clinical software and services, will convene global technology and biopharma leaders October 12-14 for its eighth annual client and partner conference, ENGAGE 2026. The company will host over 250 attendees at W Philadelphia, including representatives from over 75 life science organizations such as GSK, Moderna, Bayer, Takeda, Daiichi-Sankyo, Vertex, Eisai, ICON, and industry partner corporate sponsors including PwC a...

パリ--(BUSINESS WIRE)--（ビジネスワイヤ） -- パリを拠点とするバイオテクノロジー・AI企業のRivercellは、ヒト細胞があらゆる治療にどう反応するかについて独自のデータ基盤を構築し、その反応を予測できる細胞のワールドモデルを学習させています。同社は、HVが主導する2,500万ドルのシードラウンドを発表しました。HCVC、Alven、Bpifrance Digital Ventureも参加したこのラウンドの資金は、Rivercell独自のデータ生成プラットフォームの規模拡大、パリのウェットラボ（化学物質や生物試料を扱う実験室）の拡張、「AI Virtual Cell」プログラムの立ち上げに充てられます。Rivercellのワールドモデルは適応症に依存せず、特定の疾患の特徴ではなく、ヒト細胞が薬剤や遺伝子の変化にどう反応するかという根本原理を学習するため、疾患につながるあらゆる細胞挙動を対象に画期的な発見を促進できます。 Rivercellは2025年夏、AI企業Cardiologsを手掛けたエンジニアから起業家に転身したCEOのヤン・フルーローによって設立され...

BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec®, a privately held medical device company focused on advancing treatment options for orthopedic and spine surgery, today announced that it has entered into an exclusive license agreement with Allevion Medical for its patented Vantage™ spinal decompression technology. Under the terms of the agreement, SurGenTec® has secured exclusive rights to Allevion Medical's Vantage™, a fully disposable, sterile system designed to simplify and enhance minimally in...

HOUSTON--(BUSINESS WIRE)--The Rice Alliance for Technology and Entrepreneurship and BioHouston today announced that the 15th Annual Texas Life Science Forum is set for Tuesday, Nov. 10, at McNair Hall at Rice University. The Forum will bring together entrepreneurs, investors, industry executives, and academic and clinical leaders from Texas and nationwide to focus discussion on the promising science and technology in the state that serves as the backbone for new businesses and is an overall dri...

CHICAGO--(BUSINESS WIRE)--SullivanCotter, the nation’s leading independent consulting firm in the assessment and development of total rewards programs, workforce solutions, and data products for health care and not-for-profits, has released the latest benchmarks from its 2026 Health Care Staff Compensation Survey. This survey includes data from nearly 2,600 organizations representing 2.6 million clinical and non-clinical employees – making it one of the industry’s most comprehensive health care...

MENLO PARK, Calif.--(BUSINESS WIRE)--Hello Heart, the leader in AI-powered preventive heart health, today announced that Charles “Chuck” MacGlashing has joined the company as Chief Financial Officer as Hello Heart enters its next stage of growth. MacGlashing joins Hello Heart after more than a decade at HubSpot, where he most recently served as Senior Vice President of Treasury, Corporate Development, and Investor Relations. In that role, he was a key voice for HubSpot with investors and Wall S...